Skip to Search Skip to Navigation Skip to Content
STCEID
South Texas Center for Emerging Infectious Diseases

Upcoming Seminars

April 5, 2013

 

Monica Carson, PhD,
Associate Professor, University of California Riverside

April 12, 2013

The Vaginal Microbiome in Health and Disease

Jacques Ravel, PhD
Professor, University of Maryland School of Medicine

April 19, 2013

A Status Report on Dendritic Cells' Mechanisms of Transcriptional Control

Stephanie Watowich, PhD,
Associate Professor, UT MD Anderson Cancer Center

April 26, 2013

 

Arturo Casadevall, MD, PhD,
Professor, Albert Einstein College of Medicine

Recent News

Astrid Cardona, PhD

Dr. Astrid E. Cardona Has Won the 2012 Women of Distinction Award

(April 2012) -- The Texas Association of Mexican American Chambers of Commerce (TAMACC), the leading Hispanic business organization in Texas since 1975, is recognizing the accomplishments and contributions of some outstanding women. Each of the honorees have made a significant difference in our community and have excelled in their professions.  Continued »

Jose Lopez-Ribot, PhD

UTSA Microbiologist José López-Ribot to Serve as President of Medical Mycology Society of the Americas

(Sept 2011) -- Dr. José López-Ribot, Professor of Microbiology and Associate Director of the South Texas Center for Emerging Infectious Diseases, has been elected to serve the Medical Mycology Society of the Americas as its 2012 president. Medical mycology is the study of fungal organisms that cause infectious diseases.   Continued »

UTSA Receives $4.6 Million to Create Center of Excellence in Infection Genomics

(June 2011) -- The South Texas Center for Emerging Infectious Diseases (STCEID) at UTSA announced today it will receive $4.6 million over the next five years from the U.S. Department of Defense’s Army Research Office to establish a Center of Excellence in Infection Genomics (CEIG) to support microbiology research, teaching and outreach activities aligned with Army priorities. Infection genomics is the scientific discipline in which biologists characterize functional properties of the entire genome of infectious organisms.  Continued »

UTSA Infectious Disease Researchers Develop International Partnerships in Lebanon

(May 2011) -- Professor of Microbiology and Director of the South Texas Center for Emerging Infectious Diseases (STCEID), Dr. Karl Klose, along with colleagues Dr. Bernard Arulanandam, Associate Dean of Research for Scientific Innovation, and Dr. Janakiram Seshu, Associate Professor of Microbiology, traveled to Beirut on May 9-14 to develop international collaborations with microbiology/immunology researchers and clinicians at the American University of Beirut (AUB) in Lebanon. Their travel was funded by the U.S. Department of State through the American Association for the Advancement of Science (AAAS).  Continued »

chlamydia bacterium

Researchers from UTSA, UT Health Science Center are Granted a Patent Related to Chlamydia

(May 2011) -- Researchers Dr. Bernard Arulanandam, The Jane and Roland Blumberg Professor in Biology and Associate Dean of Research for Scientific Innovation, and Dr. Ashlesh Murthy, Research Assistant Professor and member of the South Texas Center for Emerging Infectious Diseases, and researcher Dr. Guangming Zhong, Professor of Microbiology and Immunology at The University of Texas Health Science Center at San Antonio (UTHSCSA), have together received a United States patent based on discoveries the trio made while researching Chlamydia trachomatis, the bacterium that causes chlamydia infections.  Continued »

Ashlesh Murthy, PhD

UTSA Biology Researcher Named One of a Dozen Emerging Scholars by Diverse Issues in Higher Education

(Feb 2011) -- The University of Texas at San Antonio announced today that Research Assistant Professor Dr. Ashlesh Murthy has been named one of a dozen emerging scholars under the age of 40 in the January 6 issue of Diverse Issues in Higher Education. Murthy, a medical doctor by training and the first graduate student to receive a Ph.D. in Biology from UTSA’s Cellular and Molecular Biology program, is one of a trio of San Antonio researchers working with Merck and Co. to develop and commercialize a vaccine to prevent chlamydia infection.  Continued »